FHLC
Fidelity MSCI Health Care Index ETF
The Fidelity MSCI Health Care Index ETF is an exchange-traded fund incorporated in the USA. The ETF seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care Index.
US
EQUITY
Passive
MANAGEMENT STYLE
2.7 B
ASSETS UNDER MGMT
8 bp
EXPENSES
Fund Basics
Fund sponsor | FMR LLC |
Category | US |
Asset class | Equity |
Website | link... |
Inception date | Oct 21, 2013 |
Assets (mns) | $2,735 |
Expense ratio | 8 bp |
Currency | USD |
Sector Breakdown
Fund Structure
Regulation | Open-Ended Fund |
Distributions | Quarterly |
Taxation | 1099 |
Stock selection | Market Cap |
Weighting | Market Cap |
Holdings Transparency | Full |
Derivatives-based | No |
Options available | Yes |
Currency hedged | No |
Fund of funds | No |
Top 10 Holdings
ELI LILLY & CO | 10.2 % |
UNITEDHEALTH GROUP INC | 8.3 % |
JOHNSON & JOHNSON | 6.1 % |
ABBVIE INC | 5.2 % |
MERCK & CO. INC. | 5.0 % |
THERMO FISHER SCIENTIFIC INC | 3.7 % |
DANAHER CORP | 3.0 % |
ABBOTT LABORATORIES | 2.9 % |
AMGEN INC | 2.8 % |
PFIZER INC | 2.7 % |
Constituent Breakdown
Number of holdings | 369 |
Herfindahl-Hirschman Index | 356 |
Wgt avg mkt cap (mns) | $242,693 |
Large cap (>$10bn) | 90.9% |
Mid cap ($2-10bn) | 6.7% |
Small cap (<$2bn) | 2.2% |
Developed mkts. | 100.0% |
Emerging mkts. | 0.0% |
Country Exposure
UNITED STATES | 96.4 % | |
IRELAND | 2.2 % |
Historical Performance
Standardized Performance (as of 10/31/2024)
YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | Incep. | |
---|---|---|---|---|---|---|---|
Total Returns | 8.7% | 21.2% | 7.1% | 3.0% | 10.5% | 9.7% | 11.4% | Volatility | 10.9% | 11.2% | 11.8% | 14.8% | 18.6% | 17.1% | -- |
Market Correlations
versus... | Beta | R-squared |
S&P 500 | 0.67 | 63% |
MSCI EAFE | 0.64 | 59% |
MSCI Emg Mkts | 0.37 | 20% |
Liquidity Measures
Avg. volume (000) | 109 |
Turnover | 0.3% |
Avg. Bid/Ask (% of price) | 0.04% |
ADV of underlying (mns) | $51,804 |
Technical Indicators
Recent close | $67.27 |
30d moving avg. | $71.84 |
Annualized volatility | 14.7% |
Relative strength (RSI) | 41 |
Short interest (ETF) | 0.0% |
Short interest (underlying) | 2.1% |
Distributions
Assets Under Management (mns)
Money Flows (mns)
Short Interest (as % of shares outstanding)
Long Money Flows (mns)
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
Ticker | Fund Name | Overlap vs. FHLC |
Expenses vs. FHLC |
ALTAR Score™ vs. FHLC |
---|---|---|---|---|
VHT | Vanguard Health Care ETF | 90.6% | +2 bp | -0.3% |
IYH | iShares U.S. Healthcare ETF | 87.0% | +32 bp | +0.6% |
XLV | Health Care Select Sector SPDR Fund | 85.6% | +1 bp | +1.4% |
IXJ | iShares Global Healthcare ETF | 71.8% | +34 bp | +0.5% |
RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 50.0% | +32 bp | +2.0% |
BHCHX | Baron Health Care Strategy | 43.1% | +67 bp | -6.8% |
PINK | Simplify Health Care ETF | 39.8% | +42 bp | -2.6% |
FTXH | First Trust Nasdaq Pharmaceuticals ETF | 36.6% | +52 bp | +3.8% |
HKND | Humankind US Stock ETF | 35.3% | +3 bp | +1.1% |
MEDX | Horizon Kinetics Medical ETF | 35.3% | +77 bp | -6.3% |
Risk and Returns: FHLC vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates
2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | ||
---|---|---|---|---|---|---|---|---|
Sales per share | -- | -- | -- | -- | -- | -- | -- | |
change (%) | -- | -- | -- | -- | -- | -- | -- | |
Earnings per share | -- | -- | -- | -- | -- | -- | -- | |
change (%) | -- | -- | -- | -- | -- | -- | -- | |
Dividends per share | -- | -- | -- | -- | -- | -- | -- | |
change (%) | -- | -- | -- | -- | -- | -- | -- | |
Book value per share | -- | -- | -- | -- | -- | -- | -- | |
change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
EPS Revision Activity (6 mo. ago = 100%)
Compound Annual Growth Rates
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
2023 | 2024E | Fwd Est | 2025E | |
Price-to-sales | --x | --x | --x | --x |
Price-to-earnings | --x | --x | --x | --x |
Price-to-cash flow | --x | --x | --x | --x |
Price-to-growth | --x | --x | --x | --x |
Price-to-book value | --x | --x | --x | --x |
Yield | --% | --% | --x | --% |
Based on closing prices from 11/15/2024
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
FHLC
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
NEUTRAL
Average appreciation potential. A rating of NEUTRAL is assigned to ETFs with ALTAR Scores in the middle quintile (ranking between 40%-60%) of their category. This indicates that valuations adequately reflect the fundamentals of stocks in these funds.
ALTAR Score™
FHLC
6.0%
Cat. Avg
5.5%
ALTAR Score™ Calculation
Category Overview
There are 973 funds in the US Equity category, with an average ALTAR Score™
of 5.5% and a standard deviation of
2.4%. FHLC's ALTAR Score™ is approximately
0.2 standard deviations
above
the category average. This places FHLC in the 59th percentile among funds in the category.
Sell Side Consensus Rating
Sell-side recommendations on the ETF's individual constituents
FHLCSELL
U/W
HOLD
O/W
BUY
Expense Analysis
Peer Group | Passive US Equity ETFs |
# of ETFs | 192 |
Avg. Expense Ratio | 31.0 bp |
Std. Deviation | 25.7 bp |
FHLC (8 bp) Percentile rank | 18 |
Peer Group Expense Ratio Distribution
Total Cost of Ownership (TCO) Comparison
Expense (bp) (A) |
Avg. Bid/Ask (bp) (B) |
TCO (bp) (A)+(B) |
|
---|---|---|---|
FHLC | 8.4 | 3.5 | 11.9 |
Peer Avg. | 28.8 | 6.6 | 35.4 |
For a detailed cost analysis of this and any other ETF use the TCO Comparison Tool .